Cutaneous and Systemic Reactions to Metal Implants

Description

The purpose of this study is to evaluate if metal patch testing in metal allergic patients is useful for predicting the development of allergic skin disease or systemic symptoms in patients who recieve a metal orthopedic implant.

Study Start Date

August 2014

Estimated Completion Date

August 2018

Interventions

  • Other: Patch Test

Specialties

  • Internal Medicine: Allergy/Immunology,Dermatology,Infectious Disease
  • Infectious Disease: Derm Infectious Disease
  • Family Medicine: Dermatology
  • Allergy/Immunology: Derm Allergy/Immunology
  • Dermatology: Derm Allergy/Immunology,Derm Infectious Disease

MeSH Terms

  • Dermatitis, Allergic Contact
  • Dermatitis, Contact
  • Hypersensitivity
  • Skin Diseases, Eczematous

Study ID

Winthrop University Hospital -- 14318

Status

Unknown

Trial ID

NCT02483728

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

100

Sponsor

Winthrop University Hospital

Inclusion Criteria 1. Age ?18 years with a history of metal allergy who require joint repair (hip, knee and/or shoulder) 2. Able to undergo patch testing Exclusion Criteria 1. Patients on oral immunosuppressant medications within 4 weeks of patch testing or topical corticosteroids to the back within 1 week of patch testing 2. Patients who are pregnant or breastfeeding

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Study Locations and Contact Information (2)

Study Location Distance Name Phone Email
Winthrop University Hospital - Mineola, New York 38.5 miles Marcella R Aquino MD 516-663-2097 maquino@winthrop.org
University of Cincinnati College of Medicine - Cincinnati, Ohio 612.9 miles Jonathan Bernstein MD 513-558-5533 jonathan.bernstein@uc.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.